Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 53

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 53
---
 TSR and CAP

CAP vs Company Net Income and Revenue

**42

CEO Pay Ratio

We present below the ratio of annual total compensation of our median compensated employee to the annualized total compensation of Chad Robins, our chief executive officer, calculated in accordance with Item 402(u) of Regulation S-K. Due to a decrease in our employee population for 2024, we chose to reassess our median employee. In identifying our median employee, we reviewed the compensation of our entire employee population of 620 U.S. employees as of December 31, 2024, which includes part-time employees and excludes our chief executive officer. In performing this analysis, we identified the median employee based on annual base salary rate and target bonus as of December 31, 2024 plus the grant date fair value of all equity awards granted in 2024. For purposes of the calculation, overtime paid in 2024 was annualized for days worked in 2024 and added to the annual base salary amount. With an even number of employees, two potential median employees were evaluated. One employee was employed with the company for the full year and received all compensation in the normal course. The other employee was hired late in the third quarter and their compensation would reflect this reduced period of service. For this reason, the employee who was employed for the full year was used as the median employee.After identifying the median employee, we then determined the actual annual salary paid in 2024, the cash bonus paid out for 2024 (paid in 2025), the grant date fair value of all equity awards granted in 2024, as well as other benefits such as 401(k) matching, utilizing the same method used to calculate and report Mr. Robins’ compensation in the “Summary Compensation Table.”

The 2024 total compensation for Mr. Robins, as reported in the “Summary Compensation Table,” was $4,973,301, which reflects all elements of his compensation as determined under Item 402 of Regulation S-K. The 2024 annual total compensation as determined under Item 402 of Regulation S-K for our median employee, who is employed as a Computational Biologist II, was $170,306. The ratio of Mr. Robins’ total compensation to our median employee’s total annual compensation for 2024 is 29 to 1.

Employment Arrangements with our Named Executive Officers

Chief Executive Officer – Chad Robins

We are party to an amended and restated employment agreement with Mr. Robins